Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 13, Pages -Publisher
MDPI
DOI: 10.3390/jcm10132986
Keywords
acute tubulointerstitial nephritis; T lymphocytes; biomarkers; urinary cytokines; inflammation
Categories
Funding
- Instituto de Salud Carlos III [CM19/00107]
- European Social Fund (ESF investing in your future)
- Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain) [FIS-ISCIII PI20/00812, PI17/00277]
- FEDER funds/European Regional Development Fund-a way to build Europe
Ask authors/readers for more resources
Urinary levels of inflammation-related cytokines such as I-TAC/CXCL11, CXCL10, IL6 and MCP-1 are able to accurately distinguish patients developing ATIN from ATN and healthy individuals, potentially serving as novel non-invasive biomarkers for this disease. Combining these cytokines with blood eosinophil and urinary leukocyte counts further improves accuracy in distinguishing ATIN from ATN. Follow-up samples also showed a significant decrease in certain cytokine levels among ATIN patients.
Background: Acute tubulointerstitial nephritis (ATIN) diagnosis lays on histological assessment through a kidney biopsy, given the absence of accurate non-invasive biomarkers. The aim of this study was to evaluate the accuracy of different urinary inflammation-related cytokines for the diagnostic of ATIN and its distinction from acute tubular necrosis (ATN). Methods: We included 33 patients (ATIN (n = 21), ATN (n = 12)), and 6 healthy controls (HC). We determined the urinary levels of 10 inflammation-related cytokines using a multiplex bead-based Luminex assay at the time of biopsy and after therapy, and registered main clinical, analytical and histological data. Results: At the time of biopsy, urinary levels of I-TAC/CXCL11, CXCL10, IL-6, TNF alpha and MCP-1 were significantly higher in ATIN compared to HC. A positive correlation between the extent of the tubulointerstitial cellular infiltrates in kidney biopsies and the urinary concentration of I-TAC/CXCL11, MIG/CXCL9, CXCL10, IL17, IFN alpha, MCP1 and EGF was observed. Notably, I-TAC/CXCL11, IL-6 and MCP-1 were significantly higher in ATIN than in ATN, with I-TAC/CXCL11 as the best discriminative classifier AUC (0.77, 95% CI 0.57-0.95, p = 0.02). A combinatory model of these three urinary cytokines increased the accuracy in the distinction of ATIN/ATN compared to the individual biomarkers. The best model resulted when combining the three cytokines with blood eosinophil and urinary leukocyte counts (LR = 9.76). Follow-up samples from 11ATIN patients showed a significant decrease in I-TAC/CXCL11, MIG/CXCL9 and CXCL10 levels. Conclusions: Urinary I-TAC/CXCL11, CXCL10, IL6 and MCP-1 levels accurately distinguish patients developing ATIN from ATN and healthy individuals and may serve as novel non-invasive biomarkers in this disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available